相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
Hong You et al.
HEPATOLOGY INTERNATIONAL (2022)
Multifunctional intracellular matrix metalloproteinases: implications in disease
Wesam Bassiouni et al.
FEBS JOURNAL (2021)
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
Katharine M. Irvine et al.
SCIENTIFIC REPORTS (2021)
Autoantibodies to speckled protein family in primary biliary cholangitis
Alessandro Granito et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2021)
Analysis of Autoantibodies against Promyelocytic Leukemia Nuclear Body Components and Biochemical Parameters in Sera of Patients with Primary Biliary Cholangitis
Alicja Bauer et al.
DIAGNOSTICS (2021)
A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients
Gideon M. Hirschfield et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Production and activity of matrix metalloproteinases during liver fibrosis progression of chronic hepatitis C patients
Moises Martinez-Castillo et al.
WORLD JOURNAL OF HEPATOLOGY (2021)
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase
Carla F. Murillo Perez et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Structure and Function of Human Matrix Metalloproteinases
Helena Laronha et al.
CELLS (2020)
Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases
Eline Geervliet et al.
CELLS (2020)
Epigenetic regulation of matrix metalloproteinases in inflammatory diseases: a narrative review
Jie He et al.
CELL AND BIOSCIENCE (2020)
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease
Simon Lam et al.
HEPATOLOGY COMMUNICATIONS (2020)
Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis
Praveen Sharma et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Genome-wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis
Chan Wang et al.
HEPATOLOGY (2019)
Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis
Turkan Tuncer et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2019)
The challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli Benedetta et al.
JOURNAL OF AUTOIMMUNITY (2019)
The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
Hong-Meng Chuang et al.
MOLECULES (2019)
Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis
Alicja Bauer et al.
ANNALS OF LABORATORY MEDICINE (2019)
Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching
Halina Cichoz-Lach et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
Matrix metalloproteinases and liver fibrosis (translational aspects)
Elke Roeb
MATRIX BIOLOGY (2018)
MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis
Aaron Lerner et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2018)
Biomarkers for primary biliary cholangitis: current perspectives
Elias Kouroumalis et al.
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2018)
Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis
Wataru Ando et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
Matrix Metalloproteinases (MMPs) in Liver Diseases
Adnan Naim et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2017)
Primary Biliary Cholangitis : Its Pathological Characteristics and Immunopathological Mechanisms
Koichi Tsuneyama et al.
JOURNAL OF MEDICAL INVESTIGATION (2017)
The diagnosis of antimitochondrial antibody-negative primary biliary cholangitis
Ersan Ozaslan et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland
Andrzej Prystupa et al.
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2015)
Primary biliary cirrhosis
Elizabeth J. Carey et al.
LANCET (2015)
The importance of autoantibody detection in primary biliary cirrhosis
Eduardo Luiz Rachid Cancado et al.
FRONTIERS IN IMMUNOLOGY (2015)
Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients
Abdelfattah M. Attallah et al.
ANNALS OF HEPATOLOGY (2015)
Diverse functions of matrix metalloproteinases during fibrosis
Matthew Giannandrea et al.
DISEASE MODELS & MECHANISMS (2014)
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
Willem J. Lammers et al.
GASTROENTEROLOGY (2014)
Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
Willems Stijn et al.
ANNALS OF THORACIC MEDICINE (2013)
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis
Alessandro Granito et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis
Cory M. Yamashita et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
MMP Mediated Degradation of Type VI Collagen Is Highly Associated with Liver Fibrosis - Identification and Validation of a Novel Biochemical Marker Assay
Sanne Skovgard Veidal et al.
PLOS ONE (2011)
High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia
Sittisak Honsawek et al.
PEDIATRIC SURGERY INTERNATIONAL (2011)
Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls
Steven P. Luckman et al.
AUTOIMMUNE DISEASES (2011)
PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis
Alessandro Granito et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
The Genotypes of IL-1 beta and MMP-3 are Associated with the Prognosis of HCV-related Hepatocellular Carcinoma
Kinya Okamoto et al.
INTERNAL MEDICINE (2010)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis
A. G. Richter et al.
THORAX (2009)
The role of long-term doxycycline in patients of idiopathic pulmonaryfibrosis: The results of an open prospective trial
Parthasarathi Bhattacharyya et al.
LUNG INDIA (2009)
MMPs as therapeutic targets - Still a viable option?
Barbara Fingleton
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies
Stefanie Hemmann et al.
JOURNAL OF HEPATOLOGY (2007)
Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis
A. Granito et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis
Karim Si-Tayeb et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases
R Heljasvaara et al.
EXPERIMENTAL CELL RESEARCH (2005)
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease
K Okamoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis
R Lichtinghagen et al.
CLINICAL SCIENCE (2003)
Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells
A Monvoisin et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Rat liver injury following normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor
R Cursio et al.
FASEB JOURNAL (2001)
Extracellular matrix degradation and the role of hepatic stellate cells
RC Benyon et al.
SEMINARS IN LIVER DISEASE (2001)
分享论文
